Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Disgruntled radiographer arrested after driving car through crowd of children

The tech is said to have been behind the wheel of a vehicle that drove into a group of second and third graders on their way home from school.

cancer screening puzzle

How tax policies impact cancer mortality rates

According to a new analysis, the relationship between the two is actually quite significant. 

Medicaid money dollar reimbursement

State lawmaker shelves proposal to expand Medicaid coverage for breast imaging

Florida Senate Bill 1578 was slated for consideration by the full legislature after unanimously passing through three committee votes. 

Thumbnail

POCUS slashes diagnosis times in emergency room

Point-of-care ultrasound of the lungs could expedite the diagnostic process in busy EDs, allowing providers to quickly initiate treatment for patients presenting with respiratory symptoms. 

Hologic sees drop in sales and tariff impact on stock price

The vendor's latest earnings report outlines a nearly $35 million decline in mammography sales and projected ramifications from new tariffs. 

radiation oncology therapy treatment

New data question the role radiation therapy plays in cardiovascular health

There has been back-and-forth among experts on the relationship between breast arterial calcifications and cardiovascular disease for many years.

Chipiron Evan Kervella and Dimitri Labat

Startup seeking to make MRI ‘10 times less expensive’ raises $17M

Paris, France-based Chipiron will use the Series A financing to build a prototype of its portable machine, hoping to launch clinical trials in 2026.

brain money alzheimer dementia

Lantheus to seek approval for new Alzheimer’s PET imaging agent in Q3

The declaration comes with the North Billerica, Massachusetts-based drugmaker announcing positive results from two “pivotal” studies of MK-6240.